To: Orlando Stevenson who wrote (10790 ) 5/21/1999 10:18:00 PM From: Maverick Respond to of 19080
ML latest bullish report on ORCL product win 5/20/99 Release: [PRNewswire, 14 May] Oracle announced more than 100 mid-sized companies have gone live on Oracle(R) Applications in less than six months. Merrill Lynch: As reported in our previous Enterprise Software News Weeklies, we expected Oracle's FastForward(SM) family of Applications to be extremely attractive to companies in the mid-market. The business model of out-of-the-box functionality combined with fast implementations is one being successfully executed by another Applications vendor in our group, Great Plains Software. We view this announcement as proof that Oracle has been able to deliver on its promise of ERP functionality and greatly reduced implementations. However, in the overall scheme of things, though these implementations are a solid proof of concept, they do not currently constitute a significant earnings generator. Release: [PRNewswire, 14 May] -- Drug Emporium and Oracle Corporation today announced that Drug Emporium has selected Oracle's e-business applications to expand Drug Emporium's Internet business. Merrill Lynch: Drug Emporium will integrate Oracle's e-business application (Internet Commerce Server) with Oracle Payment Server, Oracle Order Entry and Oracle Inventory. We believe Drug Emporium is typical of the customer Oracle's sales force will be targeting in the coming months ( from its Applications installed base). With such a large group to target, we expect Oracle to quickly make an impact in the e-commerce space. It is the leverage of Oracle's infrastructure products (database, tools) combined with its productivity offerings (Applications) that make it such a formidable competitor in the new E-business market.